Projects

Fast tracking Bangalore's response to HIV through a pilot community-led testing model, the first in India

Project Description

Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.

Project Duration

2016 - Ongoing

Project Lead

Dr. Tony DS Raj, Dr. Savitha Nagraj

Authors

Dr. Tony DS Raj, Dr. Savitha Nagraj

Project Status

completed

Project Type

Aidsfonds, Netherlands